- Home
- BCG vs BRNS Comparison
BCG vs BRNS Comparison
Compare BCG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCG | BRNS |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BCG | BRNS |
|---|---|---|
| Price | $1.98 | $0.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 2.0M | 103.6K |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $178,203,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $57.50 | ★ N/A |
| Revenue Growth | 10.19 | ★ 1766.46 |
| 52 Week Low | $1.36 | $0.64 |
| 52 Week High | $6.00 | $2.92 |
Technical Indicators
Market Signals| Indicator | BCG | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 46.69 | 39.99 |
| Support Level | $2.33 | $0.68 |
| Resistance Level | $3.07 | $0.78 |
| Average True Range (ATR) | 0.33 | 0.07 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 9.50 | 32.61 |
Price Performance
Historical ComparisonAbout BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.